Table 2.
Donor/recipient predictor variables | HR (CI) | Points |
Primary indication for transplant | ||
Low (P = 0.07) | ||
Standard (P = 0.05) | 2 (1-4.04) | 2 |
High (P = 0.04) | 2.83 (1.04-7.24) | 3 |
reTPL (P = 0.26) | 1.87 (0.63-5.58) | 2 |
MELD > 25 (P = 0.04) | 2.75 (1.04-7.24) | 3 |
CIT > 10 h (P = 0.6) | 1.37 (0.4-4.04) | 1 |
WIT > 25 min (P = 0.4) | 1.48 (0.6-3.63) | 1 |
dHepT | ||
40-60 min (P = 0.5) | 1.36 (0.53-3.53) | 1 |
> 60 min (P = 0.05) | 4.4 (1.02-19.04) | 4 |
Points were given to each variable in proportion to their calculated hazard ratio (HR). Primary indication for liver transplant has been divided into three risk groups of low, standard and high, as defined by their survival curves. Low DCD risk indications for transplant include autoimmune hepatitis, primary sclerosing cholangitis, primary biliary cirrhosis, non-alcoholic steatohepatitis, Hepatitis B virus and cholestatic liver disease (primary familial intrahepatic cholestasis, extrahepatic biliary atresia and Crigler Najjar). Standard risk indications were metabolic diseases that included Wilson’s, Hemochromatosis and Familial Amyloid Polyneuropathy. High risk indications for DCD transplant were alcohol related liver disease; HCV: Hepatitis C virus, cryptogenic and Budd Chiari. reTPL: Retransplantation; MELD: Model for end stage liver disease; CIT: Cold ischemic time; WIT: Warm ischemic time; dHepT: Donor hepatectomy time; HCC: Hepatocellular carcinoma.